Viatris VTRS
NASDAQ VTRS
$16.47 -0.15 (-0.87%)
As of: Sep 9, 2026 · 1:50 PM EDT

Viatris (VTRS) Cost of Revenue (2020 - 2026)

Viatris (VTRS) posted Cost of Revenue of $2.3 billion for Q2 2026, down 2.52% on a QoQ basis from $2.4 billion in Q1 2026, and up 2.27% year-over-year from $2.2 billion in Q2 2025.

Analysis

Viatris (VTRS) Cost of Revenue (2020 - 2026) Analysis & Trends

Viatris has reported Cost of Revenue for 7 years, with the latest figure at $2.3 billion in Q2 2026.

  • On a quarterly basis, Cost of Revenue rose 2.27% year-over-year to $2.3 billion in Q2 2026; TTM through Jun 2026 was $9.6 billion, a 7.34% increase from a year earlier, with the FY2025 full-year figure at $9.3 billion, up 1.87% from the prior year.
  • Cost of Revenue was $2.3 billion for Q2 2026 at Viatris, down from $2.4 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $2.6 billion in Q4 2022, with the low at $2.1 billion in Q1 2025.
  • Average Cost of Revenue over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Cost of Revenue retreated 26.72% in 2022, then advanced 12.74% in 2026.
  • Over 5 years, Cost of Revenue stood at $2.6 billion in 2022, then slipped by 13.88% to $2.2 billion in 2023, then advanced by 3.23% to $2.3 billion in 2024, then increased by 10.49% to $2.6 billion in 2025, then retreated by 9.99% to $2.3 billion in 2026.
  • The last three Cost of Revenue figures came in at $2.3 billion (Q2 2026), $2.4 billion (Q1 2026), and $2.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 42.56 Bn 38.90 Bn 2.15 Bn 1.99 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 2.30 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 455.94 Mn
4 Amneal Pharmaceuticals 5.46 Bn 5.33 Bn 334.51 Mn 461.69 Mn
5 Bausch Health Companies 2.37 Bn 528.25 Mn 2.10 Bn 753.00 Mn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 52.20 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 100.16 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 90.43 Mn
9 Fennec Pharmaceuticals 411.43 Mn 370.18 Mn 17.15 Mn 721,000.00
10 RedHill Biopharma 181.39 Mn 181.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.30 Bn
Mar 31, 2026 2.36 Bn
Dec 31, 2025 2.56 Bn
Sep 30, 2025 2.39 Bn
Jun 30, 2025 2.25 Bn
Mar 31, 2025 2.09 Bn
Dec 31, 2024 2.31 Bn
Sep 30, 2024 2.29 Bn
Jun 30, 2024 2.35 Bn
Mar 31, 2024 2.16 Bn
Dec 31, 2023 2.24 Bn
Sep 30, 2023 2.25 Bn
Jun 30, 2023 2.31 Bn
Mar 31, 2023 2.19 Bn
Dec 31, 2022 2.60 Bn
Sep 30, 2022 2.33 Bn
Jun 30, 2022 2.41 Bn
Mar 31, 2022 2.42 Bn
Dec 31, 2021 2.80 Bn
Sep 30, 2021 2.96 Bn